[ET Net News Agency, 1 April 2026] PHARMARON (03759) rose 10.1% to HK$20.72.
It hits an intra-day high of HK$20.72, breaking above the 250-D SMA of HK$20.019, and an
intra-day low of HK$19.14. The total shares traded was 10.68 million, with a value of
HK$213.9m. The active buy/sell ratio is 73:27, with net buying turnover of HK$92.89m. J.P.
MORGAN BRO (HK) accounts for greatest net responsive buying turnover of HK$1.23m, with
volume weighted average price of HK$20.019. CHINA INV INFO accounts for greatest net
responsive selling turnover of HK$27.77m, with volume weighted average price of HK$20.095.
The stock has risen a combined 13.4% over the past 2 consecutive trading days.

Basic Information
=================

----------------------------------
Nominal 20.720 % Chg +10.10%
High 20.720 Low 19.140
Shares Tr 10.68m Turnover 213.9m
10-D SMA 18.578 %H.V 53.111
20-D SMA 18.896 VWAP 20.033
50-D SMA 19.942 RSI14 59.370
----------------------------------
Status: Breaking above the 250-D SMA, active buy/sell ratio is 73:27, with net buying
turnover of HK$92.89m, rising a combined 13.4% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
PHARMARON (03759) 20.72 +10.10
INNOVENT BIO (01801) 90.75 +6.89
KEYMED BIO-B (02162) 66.95 +10.30
XTALPI (02228) 9.68 +7.44
WUXI XDC (02268) 61.75 +6.10
WUXI BIO (02269) 35.08 +6.24
WUXI APPTEC (02359) 124.30 +5.79
BEONE MEDICINES (06160) 184.90 +7.75
AKESO (09926) 139.80 +7.37
REMEGEN (09995) 109.60 +14.40
-----------------------------------------------
(ed)